131 related articles for article (PubMed ID: 21154810)
21. Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.
Chen J; Cui X; Zhou H; Qin C; Cao Q; Ju X; Li P; Cai H; Zhu J; Meng X; Wang M; Zhang Z; Shao P; Li J; Yin C
BMC Cancer; 2013 Jul; 13():356. PubMed ID: 23883402
[TBL] [Abstract][Full Text] [Related]
22. Functional genetic variants in apoptosis-associated FAS and FASL genes and risk of bladder cancer in a Turkish population.
Verim L; Timirci-Kahraman O; Akbulut H; Akbas A; Ozturk T; Turan S; Yaylim I; Ergen A; Ozturk O; Isbir T
In Vivo; 2014; 28(3):397-402. PubMed ID: 24815844
[TBL] [Abstract][Full Text] [Related]
23. Epistatic interaction between adiponectin and survivin gene polymorphisms in endometrial carcinoma.
Aminimoghaddam S; Shahrabi-Farahani M; Mohajeri-Tehrani M; Amiri P; Fereidooni F; Larijani B; Shafiee G; Amoli MM
Pathol Res Pract; 2015 Apr; 211(4):293-7. PubMed ID: 25613698
[TBL] [Abstract][Full Text] [Related]
24. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
25. Association between survivin -31G>C polymorphism and cancer risk: meta-analysis of 29 studies.
Qin Q; Zhang C; Zhu H; Yang X; Xu L; Liu J; Lu J; Zhan L; Cheng H; Sun X
J Cancer Res Clin Oncol; 2014 Feb; 140(2):179-88. PubMed ID: 24077840
[TBL] [Abstract][Full Text] [Related]
26. Association between survivin gene polymorphisms and the susceptibility to colon cancer development in the Turkish population.
Yamak N; Yaykasli KO; Yilmaz U; Eroz R; Uzunlar AK; Ankarali H; Sahiner C; Baltaci D
Asian Pac J Cancer Prev; 2014; 15(20):8963-7. PubMed ID: 25374237
[TBL] [Abstract][Full Text] [Related]
27. Survivin promoter -31G/C (rs9904341) polymorphism and cancer susceptibility: a meta-analysis.
Srivastava K; Srivastava A; Mittal B
Mol Biol Rep; 2012 Feb; 39(2):1509-16. PubMed ID: 21611748
[TBL] [Abstract][Full Text] [Related]
28. Association between survivin -31G > C promoter polymorphism and cancer risk: a meta-analysis.
Wang X; Huang L; Xu Y; Shi Z; Wang Y; Zhang J; Wang X; Cao L; Luo H; Chen J; Liu N; Yin Y; You Y
Eur J Hum Genet; 2012 Jul; 20(7):790-5. PubMed ID: 22274581
[TBL] [Abstract][Full Text] [Related]
29. The association between survivin -31G>C polymorphism and susceptibility to sporadic colorectal cancer in a Southern Chinese population.
Huang J; Wei Y; Zhou X; Wang L; Huang M; Wang J
J Cancer Res Ther; 2019; 15(1):82-86. PubMed ID: 30880759
[TBL] [Abstract][Full Text] [Related]
30. Role of TP53 Arg72Pro polymorphism in urinary bladder cancer predisposition and predictive impact of proline related genotype in advanced tumors in an ethnic Kashmiri population.
Pandith AA; Shah ZA; Khan NP; Rasool R; Afroze D; Yousuf A; Wani S; Siddiqi M
Cancer Genet Cytogenet; 2010 Dec; 203(2):263-8. PubMed ID: 21156242
[TBL] [Abstract][Full Text] [Related]
31. GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study.
Matic M; Pekmezovic T; Djukic T; Mimic-Oka J; Dragicevic D; Krivic B; Suvakov S; Savic-Radojevic A; Pljesa-Ercegovac M; Tulic C; Coric V; Simic T
Urol Oncol; 2013 Oct; 31(7):1184-92. PubMed ID: 24075358
[TBL] [Abstract][Full Text] [Related]
32. Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.
Upadhyay R; Khurana R; Kumar S; Ghoshal UC; Mittal B
Ann Surg Oncol; 2011 Mar; 18(3):880-7. PubMed ID: 20957442
[TBL] [Abstract][Full Text] [Related]
33. Survivin -31G>C polymorphism and gastrointestinal tract cancer risk: a meta-analysis.
Liu Y; Li L; Qi H; Gao Y; Liu S; Xu C
PLoS One; 2013; 8(2):e54081. PubMed ID: 23405077
[TBL] [Abstract][Full Text] [Related]
34. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
[TBL] [Abstract][Full Text] [Related]
35. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
[TBL] [Abstract][Full Text] [Related]
36. Polymorphisms of survivin and its protein expression are associated with colorectal cancer susceptibility in Chinese population.
Li XB; Li SN; Yang ZH; Cao L; Duan FL; Sun XW
DNA Cell Biol; 2013 May; 32(5):236-42. PubMed ID: 23581553
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer.
Yang H; Dinney CP; Ye Y; Zhu Y; Grossman HB; Wu X
Cancer Res; 2008 Apr; 68(7):2530-7. PubMed ID: 18381463
[TBL] [Abstract][Full Text] [Related]
38. Role of survivin re-expression in the development and progression of non-small cell lung cancer.
Javid J; Mir R; Julka PK; Ray PC; Saxena A
Tumour Biol; 2015 Jul; 36(7):5543-50. PubMed ID: 25677909
[TBL] [Abstract][Full Text] [Related]
39. Effects of TSP-1-696 C/T polymorphism on bladder cancer susceptibility and clinicopathologic features.
Gu J; Tao J; Yang X; Li P; Yang X; Qin C; Cao Q; Cai H; Zhang Z; Wang M; Gu M; Lu Q; Yin C
Cancer Genet; 2014 Jun; 207(6):247-52. PubMed ID: 25150583
[TBL] [Abstract][Full Text] [Related]
40. The association between bladder cancer and a single nucleotide polymorphism (rs2854744) in the insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) gene.
Safarinejad MR; Shafiei N; Safarinejad SH
Arch Toxicol; 2011 Oct; 85(10):1209-18. PubMed ID: 21347663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
